Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June–October 2020: A Population-Based Survey
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June–October 2020: A Population-Based Survey
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 224, Issue 2, Pages 188-195
Publisher
Oxford University Press (OUP)
Online
2021-06-04
DOI
10.1093/infdis/jiab296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The FDA’s Experience with Covid-19 Antibody Tests
- (2021) Jeffrey Shuren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Racial demographics and COVID-19 confirmed cases and deaths: a correlational analysis of 2886 US counties
- (2020) Uma V Mahajan et al. JOURNAL OF PUBLIC HEALTH
- Differential occupational risk for COVID‐19 and other infection exposure according to race and ethnicity
- (2020) Devan Hawkins AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
- (2020) Eli S. Rosenberg et al. ANNALS OF EPIDEMIOLOGY
- Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area
- (2020) Joseph Moscola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- (2020) AJ Jääskeläinen et al. JOURNAL OF CLINICAL VIROLOGY
- Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward
- (2020) Bonnie E Shook-Sa et al. JOURNAL OF INFECTIOUS DISEASES
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
- (2020) Fiona P. Havers et al. JAMA Internal Medicine
- Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020
- (2020) Holly M. Biggs et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020
- (2020) Nir Menachemi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest
- (2020) Sanni Yaya et al. BMJ Global Health
- High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
- (2020) Vivek Naranbhai et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
- (2020) Shuchi Anand et al. LANCET
- Substantial underestimation of SARS-CoV-2 infection in the United States
- (2020) Sean L. Wu et al. Nature Communications
- Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States
- (2020) Pinar Karaca-Mandic et al. JAMA Internal Medicine
- Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
- (2020) Wesley H. Self et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet
- (2020) Alexander Krüttgen et al. JOURNAL OF VIROLOGICAL METHODS
- Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
- (2020) Kristina L. Bajema et al. JAMA Internal Medicine
- Validation of Self-Reported Influenza Vaccination in the Current and Prior Season
- (2018) Jennifer P. King et al. Influenza and Other Respiratory Viruses
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started